— Various bulk drug substances
Indication: N/A (compounding)
Two-day meeting (July 23-24) to discuss bulk drug substances nominated for inclusion on the Section 503A Bulk Drug Substances List (drugs compounding pharmacies may use).
Updated weekly · 1 upcoming meeting
Upcoming FDA Advisory Committee meetings (ODAC, CRDAC, PCAC, PSPAC, and others) — the reviews that move biotech stocks. Sponsor, ticker, indication, and briefing-doc link for each. Refreshed from FDA and Federal Register weekly.
Indication: N/A (compounding)
Two-day meeting (July 23-24) to discuss bulk drug substances nominated for inclusion on the Section 503A Bulk Drug Substances List (drugs compounding pharmacies may use).
Biotech Catalyst Daily is our daily briefing covering exactly these events — every weekday, 5 min read, free.